Published in Medical Patent Law Weekly, April 23rd, 2008
"The issuance of this patent is an important achievement in the strengthening of Antares Pharma's Intellectual Property portfolio," said Dario N. R. Carrara, Senior Vice President and Managing Director of the Pharmaceutical Group. "Initially developed for the transdermal delivery of hormones, ATD Technology exhibited the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.